Institutions / Perceptive Advisors LLC / Holdings

Perceptive Advisors LLC

All holdings · as of Mar 31, 2026

Company	Class	Value ↑	Shares	% of portfolio
SURROZEN INC	—	$2.7K	166,666	0.0%
ENSYSCE BIOSCIENCES INC	—	$46.7K	86,666	0.0%
EXAGEN INC.	—	$344.7K	114,893	0.0%
REVOLUTION MEDICINES INC	—	$447.5K	250,000	0.0%
Cumberland Pharmaceuticals Inc.CPIX	Common Stock	$640.2K	196,978	0.0%
Palatin Technologies, Inc.PTN	Common Stock	$1.08M	61,945	0.0%
Medline Inc.	—	$1.25M	28,000	0.0%
CORCEPT THERAPEUTICS INC	—	$2.02M	50,000	0.0%
CONNECT BIOPHARMA HLDGS LTD	—	$2.08M	792,696	0.0%
Avalo Therapeutics, Inc.	—	$2.09M	139,667	0.0%
Adaptive Biotechnologies Corp	—	$2.12M	152,500	0.0%
Edesa Biotech, Inc.	—	$2.95M	563,239	0.1%
Outset Medical, Inc.	—	$3.20M	833,333	0.1%
Apellis Pharmaceuticals, Inc.	—	$3.26M	80,956	0.1%
CRESCENT BIOPHARMA, INC.	—	$3.80M	206,942	0.1%
Inhibikase Therapeutics, Inc.	—	$3.89M	2,315,000	0.1%
ADMA Biologics Inc	—	$4.21M	467,233	0.1%
Cogent Biosciences, Inc.	—	$4.66M	121,082	0.1%
Evolus, Inc.	—	$5.29M	1,286,862	0.1%
AgomAb Therapeutics NV	—	$6.29M	600,000	0.1%
Surrozen, Inc./DESRZN	Common Stock	$6.68M	229,393	0.1%
Twist Bioscience Corp	—	$7.13M	150,000	0.1%
BillionToOne, Inc.BLLN	Common Stock	$7.25M	91,812	0.1%
Opus Genetics, Inc.	—	$8.35M	1,835,842	0.2%
Beta Bionics, Inc.	—	$8.45M	842,944	0.2%
NEUROCRINE BIOSCIENCES INC	—	$8.57M	65,050	0.2%
Omada Health, Inc.OMDA	Common Stock	$9.88M	786,330	0.2%
Neumora Therapeutics, Inc.NMRA	Common Stock	$9.95M	5,104,097	0.2%
Phathom Pharmaceuticals, Inc.PHAT	Common Stock	$10.28M	925,000	0.2%
Evommune, Inc.EVMN	Common Stock	$10.31M	448,350	0.2%
Adagio Medical Holdings, Inc.	—	$11.01M	9,876,576	0.2%
iRhythm Holdings, Inc.	—	$12.40M	105,026	0.2%
Oculis Holding AG	—	$13.13M	493,827	0.3%
PALISADE BIO, INC.	—	$15.62M	8,928,149	0.3%
CELCUITY INC	—	$15.88M	6,500,000	0.3%
Contineum Therapeutics, Inc.	—	$16.40M	1,255,592	0.3%
Tango Therapeutics, Inc.	—	$16.91M	808,153	0.3%
Sutro Biopharma, Inc.	—	$17.82M	715,307	0.4%
Anteris Technologies Global Corp.	—	$19.01M	3,425,476	0.4%
LeonaBio, Inc.LONA	Common Stock	$19.11M	1,859,322	0.4%
DBV TECHNOLOGIES S.A.DBVT	ADR	$20.15M	964,391	0.4%
Rapport Therapeutics, Inc.RAPP	Common Stock	$21.09M	673,923	0.4%
Orchestra BioMed Holdings, Inc.OBIO	Common Stock	$21.41M	5,037,906	0.4%
Viridian Therapeutics, Inc.	—	$22.90M	1,170,829	0.5%
Axogen, Inc.	—	$23.10M	697,312	0.5%
Tenax Therapeutics, Inc.	—	$23.15M	1,447,782	0.5%
BELITE BIO, INCBLTE	ADR	$24.23M	151,979	0.5%
SAB Biotherapeutics, Inc.	—	$24.63M	6,431,743	0.5%
Revolution Medicines, Inc.	—	$25.15M	258,600	0.5%
Axsome Therapeutics, Inc.	—	$25.34M	149,950	0.5%